Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Editorial

  • Editorial
    Prognostic Factors in Multiple Myeloma
    P. Leif Bergsagel
    Clin Cancer Res February 1 2003 9 (2) 533-534;

Minireview

  • Minireview
    Modulation of Cellular Signaling Pathways
    Farhad Ravandi, Moshe Talpaz and Zeev Estrov
    Clin Cancer Res February 1 2003 9 (2) 535-550;

The Biology Behind

  • The Biology Behind
    Matrix Metalloproteinases, Angiogenesis, and Cancer
    Joyce E. Rundhaug
    Clin Cancer Res February 1 2003 9 (2) 551-554;

Advances in Brief

  • Clinical Trials

    • Advances in Brief
      A Phase I/II Trial of Intratumoral Endoscopic Ultrasound Injection of ONYX-015 with Intravenous Gemcitabine in Unresectable Pancreatic Carcinoma
      J. Randolph Hecht, Rudolph Bedford, James L. Abbruzzese, Sandeep Lahoti, Tony R. Reid, Roy M. Soetikno, David H. Kirn and Scott M. Freeman
      Clin Cancer Res February 1 2003 9 (2) 555-561;

    • Advances in Brief
      Flavopiridol-related Proinflammatory Syndrome Is Associated with Induction of Interleukin-6
      Richard A. Messmann, Claudio Dansky Ullmann, Tyler Lahusen, Audrey Kalehua, Jason Wasfy, Giovanni Melillo, Ivan Ding, Donna Headlee, William D. Figg, Edward A. Sausville and Adrian M. Senderowicz
      Clin Cancer Res February 1 2003 9 (2) 562-570;

    • Advances in Brief
      Capecitabine Induces Rapid, Sustained Response in Two Patients with Extensive Oral Verrucous Carcinoma
      Anastasios Salesiotis, Richie Soong, Robert B. Diasio, Andra Frost and Kevin J. Cullen
      Clin Cancer Res February 1 2003 9 (2) 580-585;

    • Advances in Brief
      Reduction of Wound Angiogenesis in Patients Treated with BMS-275291, a Broad Spectrum Matrix Metalloproteinase Inhibitor
      A. Craig Lockhart, Rod D. Braun, Daohai Yu, Joel R. Ross, Mark W. Dewhirst, Jeffrey S. Humphrey, Seth Thompson, Kathleen M. Williams, Bruce Klitzman, Fan Yuan, James M. Grichnik, Alan D. Proia, Delina A. Conway and Herbert I. Hurwitz
      Clin Cancer Res February 1 2003 9 (2) 586-593;

  • Clinical Trial

    • Advances in Brief
      Immunoscintigraphic Detection of the ED-B Domain of Fibronectin, a Marker of Angiogenesis, in Patients with Cancer
      Monica Santimaria, Giovanni Moscatelli, Giuseppe L. Viale, Leonardo Giovannoni, Giovanni Neri, Francesca Viti, Alessandra Leprini, Laura Borsi, Patrizia Castellani, Luciano Zardi, Dario Neri and Pietro Riva
      Clin Cancer Res February 1 2003 9 (2) 571-579;

  • Molecular Oncology, Markers, Clinical Correlates

    • Advances in Brief
      Tissue Microarray Analysis of Signal Transducers and Activators of Transcription 3 (Stat3) and Phospho-Stat3 (Tyr705) in Node-negative Breast Cancer Shows Nuclear Localization Is Associated with a Better Prognosis
      Marisa Dolled-Filhart, Robert L. Camp, Diane P. Kowalski, Bradley L. Smith and David L. Rimm
      Clin Cancer Res February 1 2003 9 (2) 594-600;

    • Advances in Brief
      High and Differential Expression of HER-2/neu Extracellular Domain in Bilateral Ductal Fluids from Women with Unilateral Invasive Breast Cancer
      Henry M. Kuerer, Patricia A. Thompson, Savitri Krishnamurthy, Herbert A. Fritsche, Sylvie M. Marcy, Gildy V. Babiera, S. Eva Singletary, Massimo Cristofanilli, Nour Sneige and Kelly K. Hunt
      Clin Cancer Res February 1 2003 9 (2) 601-605;

    • Advances in Brief
      Increase of Regulatory T Cells in the Peripheral Blood of Cancer Patients
      Anna Maria Wolf, Dominik Wolf, Michael Steurer, Guenther Gastl, Eberhard Gunsilius and Beatrix Grubeck-Loebenstein
      Clin Cancer Res February 1 2003 9 (2) 606-612;

    • Advances in Brief
      Predictive Value of the EphA2 Receptor Tyrosine Kinase in Lung Cancer Recurrence and Survival
      Michael S. Kinch, Mary-Beth Moore and David H. Harpole Jr.
      Clin Cancer Res February 1 2003 9 (2) 613-618;

  • Experimental Therapeutics, Preclinical Pharmacology

    • Advances in Brief
      CD40 Is Expressed on Ovarian Cancer Cells and Can Be Utilized for Targeting Adenoviruses
      Tanja Hakkarainen, Akseli Hemminki, Alexander V. Pereboev, Shannon D. Barker, Clement K. Asiedu, Theresa V. Strong, Anna Kanerva, Jarmo Wahlfors and David T. Curiel
      Clin Cancer Res February 1 2003 9 (2) 619-624;

Regular Articles

  • Clinical Trials

    • Regular Articles
      α1 Acid Glycoprotein Binds to Imatinib (STI571) and Substantially Alters Its Pharmacokinetics in Chronic Myeloid Leukemia Patients
      Carlo Gambacorti-Passerini, Massimo Zucchetti, Domenico Russo, Roberta Frapolli, Magda Verga, Silvia Bungaro, Lucia Tornaghi, Fabio Rossi, Pietro Pioltelli, Enrico Pogliani, Daniele Alberti, Gianmarco Corneo and Maurizio D’Incalci
      Clin Cancer Res February 1 2003 9 (2) 625-632;

    • Regular Articles
      A Pilot Study of Protracted Topotecan Dosing Using a Pharmacokinetically Guided Dosing Approach in Children with Solid Tumors
      Victor M. Santana, William C. Zamboni, Mark N. Kirstein, Ming Tan, Tiebin Liu, Amar Gajjar, Peter J. Houghton and Clinton F. Stewart
      Clin Cancer Res February 1 2003 9 (2) 633-640;

    • Regular Articles
      Enzyme-linked Immunospot, Cytokine Flow Cytometry, and Tetramers in the Detection of T-Cell Responses to a Dendritic Cell-based Multipeptide Vaccine in Patients with Melanoma
      Theresa L. Whiteside, Yongxiang Zhao, Takashi Tsukishiro, Elaine M. Elder, William Gooding and Joseph Baar
      Clin Cancer Res February 1 2003 9 (2) 641-649;

    • Regular Articles
      Increased 99mTc-Sestamibi Accumulation in Normal Liver and Drug-resistant Tumors after the Administration of the Glycoprotein Inhibitor, XR9576
      Manish Agrawal, Jame Abraham, Frank M. Balis, Maureen Edgerly, Wilfred D. Stein, Susan Bates, Tito Fojo and Clara C. Chen
      Clin Cancer Res February 1 2003 9 (2) 650-656;

    • Regular Articles
      Vaccine-induced CD8+ T-cell Responses to MAGE-3 Correlate with Clinical Outcome in Patients with Melanoma
      Sandra R. Reynolds, Anne Zeleniuch-Jacquotte, Richard L. Shapiro, Daniel F. Roses, Matthew N. Harris, Dean Johnston and Jean-Claude Bystryn
      Clin Cancer Res February 1 2003 9 (2) 657-662;

    • Regular Articles
      Phase I Evaluation of Prolonged-infusion Gemcitabine with Fludarabine for Relapsed or Refractory Acute Myelogenous Leukemia
      David A. Rizzieri, Valerie K. Ibom, Joseph O. Moore, Carlos M. DeCastro, Gary L. Rosner, David J. Adams, Traci Foster, Nancy Payne, Maria Thompson, James J. Vredenburgh, Christina Gasparetto, Gwynn D. Long, Nelson J. Chao and Jon P. Gockerman
      Clin Cancer Res February 1 2003 9 (2) 663-668;

    • Regular Articles
      Activation of Human Melanoma Reactive CD8+ T Cells by Vaccination with an Immunogenic Peptide Analog Derived from Melan-A/Melanoma Antigen Recognized by T Cells-1
      Maha Ayyoub, Alfred Zippelius, Mikaël J. Pittet, Donata Rimoldi, Danila Valmori, Jean-Charles Cerottini, Pedro Romero, Ferdy Lejeune, Danielle Liénard and Daniel E. Speiser
      Clin Cancer Res February 1 2003 9 (2) 669-677;

    • Regular Articles
      Mechanisms of Peritoneal Metastasis after Operation for Non-Serosa-invasive Gastric Carcinoma
      Takashi Marutsuka, Shinya Shimada, Kenji Shiomori, Naoko Hayashi, Yasushi Yagi, Takaaki Yamane and Michio Ogawa
      Clin Cancer Res February 1 2003 9 (2) 678-685;

    • Regular Articles
      Weekly Docetaxel as Neoadjuvant Chemotherapy for Stage II and III Breast Cancer
      Laura G. Estévez, José Miguel Cuevas, Antonio Antón, Jesús Florián, José Manuel López-Vega, Amalia Velasco, Francisco Lobo, Ana Herrero and José Fortes
      Clin Cancer Res February 1 2003 9 (2) 686-692;

    • Regular Articles
      Phase II Clinical Trial of Intralesional Administration of the Oncolytic Adenovirus ONYX-015 in Patients with Hepatobiliary Tumors with Correlative p53 Studies
      Della Makower, Alla Rozenblit, Howard Kaufman, Morris Edelman, Maureen E. Lane, James Zwiebel, Hilda Haynes and Scott Wadler
      Clin Cancer Res February 1 2003 9 (2) 693-702;

    • Regular Articles
      Phase I Clinical and Pharmacologic Study of Weekly Cisplatin and Irinotecan Combined with Amifostine for Refractory Solid Tumors
      Abdul-Kader Souid, Ronald L. Dubowy, Susan M. Blaney, Linda Hershon, Jim Sullivan, Wendy D. McLeod and Mark L. Bernstein
      Clin Cancer Res February 1 2003 9 (2) 703-710;

    • Regular Articles
      High-Dose Methotrexate for Intraocular Lymphoma
      Tracy T. Batchelor, Gina Kolak, Roberto Ciordia, C. Stephen Foster and John W. Henson
      Clin Cancer Res February 1 2003 9 (2) 711-715;

  • Molecular Oncology, Markers, Clinical Correlates

    • Regular Articles
      Prognostic Significance of Vascular Endothelial Growth Factor D in Breast Carcinoma with Long-Term Follow-Up
      Yasushi Nakamura, Hironao Yasuoka, Masahiko Tsujimoto, Qifeng Yang, Shigeru Imabun, Masaaki Nakahara, Kazuyasu Nakao, Misa Nakamura, Ichiro Mori and Kennichi Kakudo
      Clin Cancer Res February 1 2003 9 (2) 716-721;

    • Regular Articles
      Immunohistochemical Expression of CD23 and CD40 May Identify Prognostically Favorable Subgroups of Diffuse Large B-cell Lymphoma
      Johan Linderoth, Mats Jerkeman, Eva Cavallin-Ståhl, Stein Kvaløy and Emina Torlakovic
      Clin Cancer Res February 1 2003 9 (2) 722-728;

    • Regular Articles
      Up-Regulation of Tumor Interleukin-8 Expression by Infiltrating Macrophages
      Jeremy J.W. Chen, Pei-Li Yao, Ang Yuan, Tse-Ming Hong, Chia-Tung Shun, Min-Liang Kuo, Yung-Chie Lee and Pan-Chyr Yang
      Clin Cancer Res February 1 2003 9 (2) 729-737;

    • Regular Articles
      Caspase 3 in Breast Cancer
      Norma O’Donovan, John Crown, Helen Stunell, Arnold D. K. Hill, Enda McDermott, Niall O’Higgins and Michael J. Duffy
      Clin Cancer Res February 1 2003 9 (2) 738-742;

    • Regular Articles
      Methylenetetrahydrofolate Reductase 677 C→T Polymorphism and Risk of Proximal Colon Cancer in North Italy
      Giuseppe Toffoli, Roberta Gafà, Antonio Russo, Giovanni Lanza, Riccardo Dolcetti, Franca Sartor, Massimo Libra, Alessandra Viel and Mauro Boiocchi
      Clin Cancer Res February 1 2003 9 (2) 743-748;

    • Regular Articles
      Serum Antibodies to Lipophilin B Detected in Late Stage Breast Cancer Patients
      Darrick Carter, Davin C. Dillon, Lisa D. Reynolds, Marc W. Retter, Gary Fanger, David A. Molesh, Paul R. Sleath, Patricia D. McNeill, Thomas S. Vedvick, Steven G. Reed, David H. Persing and Raymond L. Houghton
      Clin Cancer Res February 1 2003 9 (2) 749-754;

    • Regular Articles
      Quantitative Molecular Detection of Minimal Residual Head and Neck Cancer in Lymph Node Aspirates
      Eline J. C. Nieuwenhuis, Lies H. Jaspars, Jonas A. Castelijns, Branco Bakker, Richard G. A. Wishaupt, Fedor Denkers, C. René Leemans, Gordon B. Snow and Ruud H. Brakenhoff
      Clin Cancer Res February 1 2003 9 (2) 755-761;

    • Regular Articles
      High Expression of Tumor Necrosis Factor-related Apoptosis-inducing Ligand Is Associated with Favorable Ovarian Cancer Survival
      Johnathan M. Lancaster, Robyn Sayer, Carrie Blanchette, Brian Calingaert, Regina Whitaker, Joellen Schildkraut, Jeffrey Marks and Andrew Berchuck
      Clin Cancer Res February 1 2003 9 (2) 762-766;

    • Regular Articles
      Molecular Determinants of Treatment Response in Human Germ Cell Tumors
      Frank Mayer, Hans Stoop, George L. Scheffer, Rik Scheper, J. Wolter Oosterhuis, Leendert H. J. Looijenga and Carsten Bokemeyer
      Clin Cancer Res February 1 2003 9 (2) 767-773;

    • Regular Articles
      Increased Plasma Ghrelin Level in Lung Cancer Cachexia
      Yoshito Shimizu, Noritoshi Nagaya, Takeshi Isobe, Michinori Imazu, Hiroyuki Okumura, Hiroshi Hosoda, Masayasu Kojima, Kenji Kangawa and Nobuoki Kohno
      Clin Cancer Res February 1 2003 9 (2) 774-778;

    • Regular Articles
      Level of Id-1 Protein Expression Correlates with Poor Differentiation, Enhanced Malignant Potential, and More Aggressive Clinical Behavior of Epithelial Ovarian Tumors
      Monika Schindl, Sebastian F. Schoppmann, Thomas Ströbel, Harald Heinzl, Christina Leisser, Reinhard Horvat and Peter Birner
      Clin Cancer Res February 1 2003 9 (2) 779-785;

    • Regular Articles
      Combination of Dihydropyrimidine Dehydrogenase and Thymidylate Synthase Gene Expressions in Primary Tumors as Predictive Parameters for the Efficacy of Fluoropyrimidine-based Chemotherapy for Metastatic Colorectal Cancer
      Wataru Ichikawa, Hiroyuki Uetake, Yoshinori Shirota, Hiroyuki Yamada, Naoto Nishi, Zenro Nihei, Kenichi Sugihara and Renzo Hirayama
      Clin Cancer Res February 1 2003 9 (2) 786-791;

    • Regular Articles
      Thymidylate Synthase Expression in Advanced Colorectal Cancer Predicts for Response to Raltitrexed
      David C. Farrugia, Hugo E. R. Ford, David Cunningham, Kathleen D. Danenberg, Peter V. Danenberg, Jan Brabender, A. David McVicar, G. Wynne Aherne, Anthea Hardcastle, Keith McCarthy and Ann L. Jackman
      Clin Cancer Res February 1 2003 9 (2) 792-801;

    • Regular Articles
      Carbonic Anhydrase IX Is an Independent Predictor of Survival in Advanced Renal Clear Cell Carcinoma
      Matthew H. T. Bui, David Seligson, Ken-ryu Han, Allan J. Pantuck, Frederick J. Dorey, Yunda Huang, Steve Horvath, Bradley C. Leibovich, Shefali Chopra, Shu-Yuan Liao, Eric Stanbridge, Michael I. Lerman, Aarno Palotie, Robert A. Figlin and Arie S. Belldegrun
      Clin Cancer Res February 1 2003 9 (2) 802-811;

    • Regular Articles
      Real-Time Analysis of Tyrosine Hydroxylase Gene Expression
      Lambert H. J. Lambooy, Corrie E. M. Gidding, Lambert P. van den Heuvel, Christina A. Hulsbergen-van de Kaa, Marjolijn Ligtenberg, Jos P. M. Bökkerink and Ronney A. De Abreu
      Clin Cancer Res February 1 2003 9 (2) 812-819;

    • Regular Articles
      Low p27Kip1 Expression Is an Independent Adverse Prognostic Factor in Patients with Multiple Myeloma
      Martin Filipits, Gudrun Pohl, Thomas Stranzl, Hannes Kaufmann, Jutta Ackermann, Heinz Gisslinger, Hildegard Greinix, Andreas Chott and Johannes Drach
      Clin Cancer Res February 1 2003 9 (2) 820-826;

    • Regular Articles
      RNA Expression of Breast Cancer Resistance Protein, Lung Resistance-related Protein, Multidrug Resistance-associated Proteins 1 and 2, and Multidrug Resistance Gene 1 in Breast Cancer
      Herman Burger, John A. Foekens, Maxime P. Look, Marion E. Meijer-van Gelder, Jan G. M. Klijn, Erik A. C. Wiemer, Gerrit Stoter and Kees Nooter
      Clin Cancer Res February 1 2003 9 (2) 827-836;

    • Regular Articles
      Sequence Alterations in the Reduced Folate Carrier Are Observed in Osteosarcoma Tumor Samples
      Rui Yang, Rebecca Sowers, BethAnne Mazza, John H. Healey, Andrew Huvos, Holcombe Grier, Mark Bernstein, G. Peter Beardsley, Mark D. Krailo, Meenakshi Devidas, Joseph R. Bertino, Paul A. Meyers and Richard Gorlick
      Clin Cancer Res February 1 2003 9 (2) 837-844;

    • Regular Articles
      Establishment and Characterization of Cancer Cell Cultures and Xenografts Derived from Primary or Metastatic Mullerian Cancers
      Claire F. Verschraegen, Wei Hu, Yu Du, John Mendoza, Janet Early, Michael Deavers, Ralph S. Freedman, Robert C. Bast Jr., Andrzej P. Kudelka, John J. Kavanagh and Beppino C. Giovanella
      Clin Cancer Res February 1 2003 9 (2) 845-852;

    • Regular Articles
      Macrophage Migration Inhibitory Factor and CXC Chemokine Expression in Non-Small Cell Lung Cancer
      Eric S. White, Kevin R. Flaherty, Shannon Carskadon, Ashley Brant, Mark D. Iannettoni, John Yee, Mark B. Orringer and Douglas A. Arenberg
      Clin Cancer Res February 1 2003 9 (2) 853-860;

  • Experimental Therapeutics, Preclinical Pharmacology

    • Regular Articles
      Apoptosis by Leukemia Cell-targeted Diphtheria Toxin Occurs via Receptor-independent Activation of Fas-associated Death Domain Protein
      Jacqueline Thorburn, Arthur E. Frankel and Andrew Thorburn
      Clin Cancer Res February 1 2003 9 (2) 861-865;

    • Regular Articles
      Combined Targeted Inhibition of bcl-2, bcl-XL, Epidermal Growth Factor Receptor, and Protein Kinase A Type I Causes Potent Antitumor, Apoptotic, and Antiangiogenic Activity
      Giampaolo Tortora, Rosa Caputo, Vincenzo Damiano, Roberta Caputo, Teresa Troiani, Bianca Maria Veneziani, Sabino De Placido, Angelo Raffaele Bianco, Uwe Zangemeister-Wittke and Fortunato Ciardiello
      Clin Cancer Res February 1 2003 9 (2) 866-871;

    • Regular Articles
      Microglia Cyclooxygenase-2 Activity in Experimental Gliomas
      Behnam Badie, Jill M. Schartner, Aaron R. Hagar, Sakthivel Prabakaran, Todd R. Peebles, Becky Bartley, Samir Lapsiwala, Daniel K. Resnick and Jessica Vorpahl
      Clin Cancer Res February 1 2003 9 (2) 872-877;

    • Regular Articles
      Phytosphingosine Induces Apoptotic Cell Death via Caspase 8 Activation and Bax Translocation in Human Cancer Cells
      Moon-Taek Park, Jung A Kang, Jung-A Choi, Chang-Mo Kang, Tae-Hwan Kim, Sangwoo Bae, Seongman Kang, Sujong Kim, Weon-Ik Choi, Chul-Koo Cho, Hee-Yong Chung, Yun-Sil Lee and Su-Jae Lee
      Clin Cancer Res February 1 2003 9 (2) 878-885;

    • Regular Articles
      Docetaxel Enhances the Therapeutic Effect of the Angiogenesis Inhibitor TNP-470 (AGM-1470) in Metastatic Human Transitional Cell Carcinoma
      Keiji Inoue, Masakazu Chikazawa, Satoshi Fukata, Chiaki Yoshikawa and Taro Shuin
      Clin Cancer Res February 1 2003 9 (2) 886-899;

    • Regular Articles
      In Vitro Schedule-dependent Interaction between Docetaxel and Gemcitabine in Human Gastric Cancer Cell Lines
      Luca Ricotti, Anna Tesei, Franca De Paola, Paola Ulivi, Giovanni Luca Frassineti, Carlo Milandri, Dino Amadori and Wainer Zoli
      Clin Cancer Res February 1 2003 9 (2) 900-905;

    • Regular Articles
      Clinical Evaluation of Mitoxantrone and Piroxicam in a Canine Model of Human Invasive Urinary Bladder Carcinoma
      Carolyn J. Henry, Dudley L. McCaw, Susan E. Turnquist, Jeff W. Tyler, Lina Bravo, Sarah Sheafor, Rodney C. Straw, William S. Dernell, Bruce R. Madewell, Linda Jorgensen, Michael A. Scott, Mary Lynn Higginbotham and Ruthanne Chun
      Clin Cancer Res February 1 2003 9 (2) 906-911;

Letters to the Editor

  • Letters to the Editor
    Correspondence re: C. G. Ferreira et al., Apoptosis: Target of Cancer Therapy. Clin. Cancer Res., 8: 2024–2034, 2002.
    Elisabeth G. E. de Vries, Marjolein N. de Hooge, Jourik A. Gietema and Steven de Jong
    Clin Cancer Res February 1 2003 9 (2) 912-912;

  • Letters to the Editor
    Reply
    Carlos G. Ferreira, Mirjam Epping, Frank A. E. Kruyt and Giuseppe Giaccone
    Clin Cancer Res February 1 2003 9 (2) 913-914;

Correction

  • Correction
    Correction for vol. 8, p. 3796
    Clin Cancer Res February 1 2003 9 (2) 915-915;

Back to top
PreviousNext
Clinical Cancer Research: 9 (2)
February 2003
Volume 9, Issue 2
  • Table of Contents
  • About the Cover

Sign up for alerts

Issue Highlights

  • Immunoscintigraphic Detection of the ED-B Domain of Fibronectin, a Marker of Angiogenesis, in Patients with Cancer
  • A Phase I/II Trial of Intratumoral Endoscopic Ultrasound Injection of ONYX-015 with Intravenous Gemcitabine in Unresectable Pancreatic Carcinoma
  • Flavopiridol-related Proinflammatory Syndrome Is Associated with Induction of Interleukin-6

Jump to

  • Editorial
  • Minireview
  • The Biology Behind
  • Advances in Brief
    • Clinical Trials
    • Clinical Trial
    • Molecular Oncology, Markers, Clinical Correlates
    • Experimental Therapeutics, Preclinical Pharmacology
  • Regular Articles
    • Clinical Trials
    • Molecular Oncology, Markers, Clinical Correlates
    • Experimental Therapeutics, Preclinical Pharmacology
  • Letters to the Editor
  • Correction
Advertisement
  • Most Cited
  • Most Read
Loading
  • Immune Checkpoint Blockade Requires Macrophage CXCL9/CXCL10
  • PDAC and GATA6 Expression
  • Characterization of Glioblastoma Patient-Derived Xenografts
  • Guadecitabine and Carboplatin in Ovarian Cancer
  • Toxicity Management Affects Checkpoint Inhibitor Efficacy
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement